Starts in:
In-person Professional Development Courses
All times listed are in MOUNTAIN STANDARD TIME
Sunday Courses
Sunday, November 3, 2024
JW Marriott Phoenix Desert Ridge
Sunday, October 26, 2025, 8:00 AM – 5:00 PM
14. Facility Commissioning and Recommissioning for the BSL-3 Laboratory
The biosafety professional can assist with the start-up or maintenance of laboratory operations in support of their biosafety programs by understanding the commissioning and recommissioning processes. Laboratory commissioning, identified in containment guidance documents, is a quality assurance process for the effective functioning of biocontainment laboratories. The biosafety officer and other decision makers benefit by having a basic understanding of the commissioning and recommissioning processes and resulting documentation. This course will review the phases of the new facility commissioning process and similar process for recommissioning. This knowledge base allows the biosafety professional to recognize how commissioning assists in providing and documenting a properly operating facility. A review of the secondary containment features of the BSL-3 laboratory will be disucssed and note specific issues typically observed. There will be a focus on two issues, the reversal of directional airflow and sealing of surfaces and penetrations. Attendees will consider methods to identify the issues and present some specific mitigations of these issues; can actively participate in the commissioning/recommissioning processes and understand the methodology, the tools, results, and their interpretation; will know their facility operates correctly, its limitations, and the risk when it does not. This knowledge allows the biosafety professional to check or back check the containment spaces’ performance and use this knowledge to perform daily inspections for maintenance or replacement and control risk to the lowest level. The biosafety professional can identify required features in a new laboratory or review an existing lab with a better understanding of typical issues to assure safe reliable operations.
Objectives:
- Develop an understanding of the overall commissioning and recommissioning processes for containment labs
- Articulate the engineering controls required and effectively participate in the processes
- Identify typical issues observed during commissioning/recommissioning of the laboratory secondary containment barriers and the options for practical solutions to those issues
- Demonstrate a knowledge base and provide documentation to better perform daily inspections to reduce risk for safe and reliable laboratory operations
Suggested Background: None
Target Audience: All Safety Professionals, Laboratory Workers, Operations and Maintenance Personnel
Audience Level: Intermediate
COURSE FACULTY
Joby Evans has over 35 years in facilities commissioning, support, design, engineering, energy management, and processes for consulting engineering firms, performance contracting group, natural gas distributor, and an international architect/developer. Mr. Evans is proficient in commissioning and in recommissioning high-containment facilities, analyzing the interaction between designs and energy consumption in commercial and industrial facilities and has extensive experience in building commissioning and system design and coordination. He has performed commissioning for BSL-4, BSL-3Ag, BSL-3 laboratories using BMBL, NIH, WHO, ANSI biosafety guidelines. His work has been in the United States and in international locations. Mr. Evans has performed re-commissioning and retro-commissioning on many non-containment facilities including headquarters facilities, hangers, office buildings, etc. He is a Registered Professional Engineer, Licensed Mechanical Contractor, Certified Building Commissioning Professional, Certified Energy Manager, Certified Green Building Engineer, and Guiding Principles Compliance Professional.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 8:00 AM – 5:00 PM
15. Advanced Risk Assessment
In this advanced and interactive course, attendees will evaluate a variety of challenging scenarios based on actual research protocol submissions and real-world events from multiple risk perspectives. Attendees will work in teams to conduct risk assessments on a diverse selection of scenarios that will include multiple systems used in research as a research project progresses from discovery to cell culture, to small animal models using recombinant materials, and human clinical trials. Risk assessments will focus on the likelihood of exposure and the severity of consequences from exposure to the multitude of hazards encountered in increasingly complex research as well as the surprises that may come across the biosafety officer’s desk. Attendees will be challenged to consider additional risks aside from infection and how best to mitigate them. Attendees should have a thorough understanding of pathogenic microorganisms, rDNA principles, other infectious substances and the link between biosafety, risk assessment, and risk mitigation for this advanced course. There is an emphasis on the interactive nature of the risk assessment process and differing views of risk tolerance will be considered; attendees should be prepared to participate in discussions and bring interesting or difficult examples of interest to them to discuss with the class.
Objectives:
- Prioritize risks based on the likelihood and consequences of an occurrence
- Identify risks requiring mitigation and mitigation strategies to minimize the unacceptable risks
- Identify institutional and external partners to help implement mitigation strategies
- Evaluate mitigation strategies for effectiveness, adjust strategies as warranted
Suggested Background: Fundamentals of Biosafety, Microbiology, and Molecular Biology, Basic Risk Assessment, Principles & Practices of Biosafety
Target Audience: Experienced Biosafety Professionals, Laboratory Workers
Audience Level: Advanced
COURSE FACULTY
Dr. David Harbourt is a Safety and Occupational Health Manager for the Center of Veterinary Medicine at the U.S. Food and Drug Administration (FDA). Prior to his current position, he served as the Program Director of the National Biosafety and Biocontainment Training Program (NBBTP) at the National Institutes of Health. Before that, he served in a variety of roles at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) including Biosafety Officer, Chief of the Biosafety Division and Deputy Director of the USMARIID Transition Office (2012-2021). Prior to working at USAMRIID, he was a fellow in the NBBTP. Preceding the fellowship, he graduated with his B.S. in Biochemistry from Virginia Tech (’05) and his Ph.D. in Toxicology from UNC-Chapel Hill (’09).
Dr. Harbourt has been an active member of ABSA International since 2010; has previously served as the Chair of the Preconference Course Committee and Chair of the Training Tools and Resources Committee; and currently serves as a member of the Exam Development Board for the CBSP Exam. He has also been a member of the Standards Committee, Professional Development Team, and BSAT Community Advocate Committee for ABSA. He has recently been named Co-Chair of the ABSA Ambassadors Committee. Locally within the Chesapeake Area Biosafety Association, Dave has been a Councilor, Chair of the Scientific Program Committee for its annual symposium, and Chair of the Pre-Symposium Committee. Previously, Dr. Harbourt served as Chair of the DoD Biosafety and Scientific Review Panel.
Dr. Harbourt has published several articles on topics relevant to biosafety including bacteriology, virology, agent inactivation, effluent decontamination systems, and risk assessment. He has also taught courses both at ABSA and at local universities on biosafety, risk assessment, emergency management, and effluent decontamination systems. Dave is a Registered Biosafety Professional and Certified Biological Safety Professional through ABSA International and a Specialist Microbiologist (NRCM) through the American Society of Microbiology.
Katie George lives in Missoula, Montana and is currently an Associate Partner and Human Gene Therapy Biosafety Officer for Clinical Biosafety Services (Chesterfield, MO) working with clinics, universities, and hospitals in the United States and Canada prepare for IBC review of Human Gene Therapy (HGT) clinical trials.
Katie holds a BS in Biology from the University of Iowa, a PhD in Biochemistry from Northwestern University, and an MPA from Purdue University. After obtaining her PhD, she was a post-doctoral fellow at the National Institutes of Health researching mycobacterial pathogenesis. After her post-doctoral position, she served as faculty at the University of Montana teaching and leading a research team studying organophosphate pesticide toxicology. Later, she taught medical students at the Medical University of the Americas (Nevis, West Indies). During her career, Katie has worked as a toxicology consultant for the State of Montana Public Defenders and the State of Montana Department of Public Health and Human Services.
Katie has been an ABSA member since 2020 and a Registered Biosafety Professional since 2021. She currently serves on the Distance Learning Committee for ABSA International.
Berenice Arriaga works at The University of Texas at El Paso, as the Assistant Director and Biosafety Officer in the office of Environmental Health and Safety. She received her bachelor’s in science (BS) in Microbiology and a master’s in business administration (MBA) with a Nursing concentration from The University of Texas at El Paso. Being a native from El Paso, TX, she started her career pretty early on volunteering in a Chagas Disease laboratory at UTEP. She later became the Laboratory Coordinator of the Howard Hughes Medical Institute (HHMI) grant at UTEP. Here she oversaw the Prokaryotic Molecular Genetics (PMG) and Molecular Cell Biology (MCB) courses. Her biosafety career started in 2010 when she became the Biocontainment Safety Manager for the Biosafety Level 3 laboratories at UTEP. In this position, she was promoted to Biosafety Officer and obtained her Specialist Microbiology (SM) certification from the National Registry of Certified Microbiologist (NRCM). She is credentialed as well as a Certified Biological Safety Professional (CBSP) through ABSA and an Associate Professional through the Board of Certified Safety Professionals.
She currently oversees the Biosafety, Food Safety, Occupational Health, Indoor Air Quality, Ergonomics, Laboratory Safety Inspection and Workers Compensation Programs at UTEP. As an active member of ABSA, she serves currently in the Distant Learning Committee (DLC) and is currently serving as a Board member in the Southern Biosafety Association (SBA). This year 2024 she hosted at UTEP the first International Symposium in joint collaboration with SBA, AMEXBIO and ABSA. This was the first biosafety symposium between the USA and Mexico both hosted in person/virtual and in English/Spanish.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 8:00 AM – 5:00 PM
16. ISO35001 Implemenation Workshop
In 2019, ISO published a new biorisk management standard that many biomedical research laboratories all over the world are adopting. This workshop will provide presentations, facilitated discussions, and tools to introduce concepts related to biosecurity and biosafety (biorisk) management systems. Attendees will gain a deep understanding of biorisk management (BRM) systems and learn to apply the ISO 35001 framework as a strategic planning tool. The course guides participants in mapping their current systems to the ISO standard, identifying gaps, and prioritizing improvements to enhance biosafety and biosecurity practices. Using the ISO 35001 as a planning and mapping tool, will enable institutions to effectively identify, assess, control, and monitor the laboratory biosafety and biosecurity risks associated with hazardous biological materials using the concept of continual improvement through the PDCA (Plan-Do-Check-Act) principle.
Objectives:
- Identify the key elements of a BRM system based on the review sections of the ISO 35001 BRM system standard
- Map existing BRM systems to the ISO 35001 and identify both strengths and opportunities to improve existing system
- Prioritize elements or areas that need improvement
- Select an area for improvement and identify a simple, short term, project idea to help strengthen one element within the existing system
Suggested Background: None
Target Audience: Experienced Biosafety Professionals, All Safety Professionals
Audience Level: Advanced
COURSE FACULTY
Eric Cook, MPH
Senior Member – Technical Staff
Sandia National Laboratories
Albuquerque, NM
Eric Cook is a Senior Member of the Technical Staff in the International Biological and Chemical Threat Reduction Program at Sandia National Laboratories where his work focuses on promoting global laboratory biorisk management. He serves as one of the program’s lead trainers. Eric served as the Biosafety Officer for Dartmouth College in Hanover, NH for five years where he managed the Biosafety Program and Institutional Biosafety Committee. Prior to working at Dartmouth, Eric was an Assistant Biosafety Officer at the Massachusetts Institute of Technology for six years. While at MIT, Eric completed his Master’s Degree in Public Health at Boston University with a focus on Environmental Health. Eric has a B.S.in Molecular Biology from Brigham Young University where he worked in a recombinant DNA lab for two years assisting with work in phylogenetics. He is certified by the National Registry of Certified Microbiologists as a Specialist Microbiologist in Biological Safety Microbiology and previously by ABSA International as a Certified Biological Safety Professional. Eric has particular expertise in dangerous goods and infectious substance shipping. He worked for three years at Saf-T-Pak, Inc. developing training programs and packaging for shipping infectious substances.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 8:00 AM – 12:00 PM
17. Lessons Learned to Improve Biosafety
Preventing laboratory-acquired infections (LAIs) is a challenge for laboratory managers and biosafety professionals, especially when dealing with an emerging pathogen. It is extremely important to quickly determine if there has been an exposure, how many may have been exposed, what steps need to happen next, including any prophylaxis, root cause analysis, gaps in the biosafety plan, and additional mitigation measures that need to be implemented. This interactive course will examine published papers from the ABSA LAI Database on laboratory acquired infections and exposures to determine what we can learn to prevent future exposures. Attendees will thoroughly examine the literature on the history of lab-acquired infections, review specific published articles, utilize the Association of Public Health Laboratories (APHL) ‘Laboratory Exposure Assessment and Symptom Monitoring Guide’ (exposure assessment tool) to assess exposures, analyze data to identify root causes of exposures, discuss identified gaps, and establish additional steps required to mitigate risks. Attendees will be equipped with the skills to assess and mitigate exposure risks using the APHL Exposure Assessment Tool. Attendees will engage in scenario-based group exercises, applying a structured process to evaluate potential exposures, conduct root cause analyses, identify procedural gaps, and develop effective mitigation strategies. Through hands-on practice and guided instruction, attendees will also learn to incorporate published data on laboratory-acquired infections (LAIs) to enhance biosafety protocols. Special emphasis will be placed on applying these tools to safely manage risks associated with emerging pathogens.
Objectives:
- Describe how the ABSA LAI database can be used for biosafety training and determining how to safely work with emerging pathogens
- Utilize the APHL exposure assessment tool to assess real-life laboratory incidents for potential exposures and to help guide prophylaxis if indicated
- Analyze actual laboratory incidents to determine the root cause and what steps are necessary to mitigate future incidents
Suggested Background: Fundamentals of Biosafety, Risk Assessment
Target Audience: All Safety Professionals, Laboratory Workers
Audience Level: Intermediate
COURSE FACULTY
Dr. Pentella is a Clinical Professor at the University of Iowa, College of Public Health and Director of the Iowa State Hygienic Laboratory. His experience spans over forty years in clinical microbiology and public health laboratories. He is certified as an American Board of Medical Microbiology Diplomate, a specialist in microbiology through the American Society for Clinical Pathology and certified in infection control through the Association of Professionals in Infection Control. Dr. Pentella is a member of the APHL Biosafety and Biosecurity Committee, Antibiotic Resistance Lab Workgroup, the Infectious Disease Committee, and the Respiratory Viruses Subcommittee. He has made several contributions that have improved the practice of clinical microbiology and biosafety. He has written over 50 articles and twenty book chapters.
Erin Bowles is the Laboratory Network Coordinator for the Wisconsin State Laboratory of Hygiene’s Communicable Disease Division, where she provides outreach and education to more than 125 laboratories in Wisconsin in order to ensure a coordinated statewide response to any biological threats of public health importance. Her background in clinical microbiology and expertise in biosafety serve her well as a member of APHL’s Workforce Development Committee, the Sentinel Laboratory Outreach and Partnership Subcommittee, and the Sentinel Laboratory Training Special Interest Group. Some of the committee projects that she has contributed to are revisions to the ASM Sentinel Level Clinical Laboratory Guidelines and the development of risk assessment training and biosafety tools such as the “Clinical Laboratory Preparedness and Response Guide”.
Shoolah Escott is currently an independent, Biosafety, Biosecurity, and Bioterrorism Preparedness Trainer and a COVID-19 Contact Tracer with Partners In Health. She was the Biosafety Manager and ARO at the MA State Public Health Laboratory for over 2 years where she provided biosafety training and support to over 50 clinical laboratories and to internal public health laboratory staff. She worked for APHL/CDC National Laboratory Training Network, CDC Laboratory Training Branch for over 17 years developing, implementing, delivering, and presenting national training programs in biosafety, biosecurity and bioterrorism preparedness. She has a strong background in clinical microbiology and was the safety officer for the Memorial Hospital clinical laboratory. Currently, she serves on several ABSA and APHL committees. Here are a few key biosafety accomplishments: What Constitutes an Effective Biosafety Plan at the World Microbe Forum; Biosafety and Biosecurity: Minimizing the Risks in the Laboratory and Clinical Laboratory Biosafety Risk Assessment seminars presented nationally multiple times; and the lead on the initial development and revision of the Clinical Laboratory Preparedness and Response Guide.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 8:00 AM – 12:00 PM
18. Flipping the Table: Effective Tabletop Exercise Design and Execution
Tabletop exercises (TTXs) are an essential part of a biosafety professional’s toolkit. It offers a safe, efficient way to “stress test” the resilience of an organization’s protocols in the face of hypothetical worse-case scenarios, making them particularly valuable for reinforcing staff training, enhancing coordination and communication between teams and team members, and identifying opportunities to improve plans and procedures. Additionally, TTXs can be used to help develop new processes and procedures in support of the stand up or expansion of activities, serving as a platform for identifying critical supporting processes and procedures that need to be in place for the activity to be completed effectively. The effectiveness of tabletop exercises (TTXs) in identifying areas for improvement can be undermined by poor planning, weak execution, and insufficient follow-up. In this course, attendees will develop an understanding of when and why they should consider conducting a TTX, participate in the development of a mock exercise, and propose appropriate follow-up actions to their exercise.
Objectives:
- Identify when, why, and what type of TTX would be useful to achieve a specific outcome
- Analyze the effort needed to design and conduct an effective TTX
- Describe appropriate follow-up actions to a TTX that ensure the continual improvement of the process or program test
Suggested Background: None
Target Audience: New Biosafety Professionals, All Safety Professionals
Audience Level: Basic
COURSE FACULTY
Dr. Sharon Altmann is a Capability Manager II/Principal Scientist supporting biosafety and global engagement as part of the Integrated Health, Surveillance, and Diagnostics unit at MRIGlobal. She received her PhD in Microbiology from the University of Wisconsin—Madison, completed a postdoctoral fellowship at the National Institutes of Health-National Institute of Allergy and Infectious Diseases, and currently holds both RBP and CBSP credentials from ABSA International. With MRIGlobal, Dr. Altmann has supported multiple international engagements, including BSL-3 laboratory training in Kazakhstan; Ebolavirus outbreak response and survivor study activities; laboratory design and capacity building efforts in West Africa; BSL-4 facility standup and core laboratory support; pandemic-related return-to-work planning for schools and businesses; CLIA laboratory stand-up and operations; and biorisk management training program development for multiple clients. Dr. Altmann currently serves as a Councilor for the Chesapeake Area Biological Safety Association (ChABSA).
Scott Shearrer is a Senior Engineer and technical lead in the biosafety and global engagement team at MRIGlobal. He has over 25 years’ experience working in biosafety and biocontainment facilities overseeing the operations of BSL-4, BSL-3, ABSL-3 and BSL-2 laboratories. Mr. Shearrer has a degree in mechanical engineering and holds an RBP from ABSA International. Mr. Shearrer has supported multiple international engagements: First with a 2 year deployment to Kazakhstan providing technical assistance for the completion of two high containment laboratories, and second, assisting with operational support of mobile diagnostic laboratories in West Africa. Mr. Shearrer has previously been an ABSA course instructor on “Responding to Emergencies in Biosafety Laboratories” and has presented at multiple ABSA International-sponsored conferences. He is a current member of ABSA International’s International Engagement Committee.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 1:00 PM – 5:00 PM
19. Boots on the Ground: Developing Field Laboratories in Resource-Limited Settings
This course provides attendees with the knowledge and practical skills needed to conduct research and clinical trials in international settings. It covers key aspects of fieldwork, including ethical considerations, cultural competency, regulatory requirements, data collection methods, and logistical challenges. Attendees will explore case studies and participate in hands-on training to develop strategies for navigating diverse healthcare environments, working with local stakeholders, and ensuring compliance with global research standards. Attendees will conclude the course equipped to design and implement field research projects in international contexts, addressing real-world health challenges while upholding scientific integrity and ethical responsibility.
Objectives:
- Design and Plan Fieldwork—Create a research or clinical trial protocol that includes logistics, site selection, stakeholder collaboration, and risk mitigation
- Manage Challenges in Global Research—Identify and develop solutions for common challenges such as regulatory approvals, weather emergencies, infrastructure limitations, and data security
- Implement Data Collection Methods—Utilize appropriate qualitative and quantitative data collection techniques suited for international and resource-limited settings
Suggested Background: None
Target Audience Laboratory Workers, All Safety Professionals
Audience Level: Basic
COURSE FACULTY
Krystle Hensley is the BSL4 Manager at the National Bio and Agro-Defense Facility (NBAF), a critical facility within the Agricultural Research Service of the USDA. In this role, she helps facilitate the standup of the BSL4 program and maximum containment research related to zoonotic and emerging diseases and agricultural threats. Prior to joining NBAF she worked at the Integrated Research Facility – NIAID supporting international programs and clinical trials, as well as establishing laboratory capacity in West Africa. She holds a Master of Public Health and Tropical Medicine from Tulane University and has experience in BSL3 and BSL4 research laboratories. Krystle is dedicated to advancing knowledge and contributing to cutting-edge scientific efforts to protect against emerging infectious diseases and biological threats.
Dr. Gene Olinger is Professor of Microbiology & Immunology and Director of the Galveston National Laboratory (GNL) at UTMB, one of the largest maximum containment laboratories in the United States. A leading expert in biosafety and biosecurity, Dr. Olinger brings extensive experience in the safe operation and oversight of high- and maximum containment laboratories. He is ISO 35001 and ISO 9001 Lead Auditor trained, with a strong focus on biorisk management systems and quality assurance. Throughout his career, he has led multidisciplinary teams in developing and implementing biosafety practices that support research on high-consequence pathogens. As GNL Director, he continues to advance international standards for biosafety and biosecurity while fostering global collaborations to strengthen preparedness and response to infectious disease threats.
Dr. Chad E. Mire serves as the NBAF Research Leader for the Foreign Anthropod-Borne Animal Diseases Research Unit under the United States Department of Agriculture (USDA). Prior to joining the USDA, Dr. Mire has worked at the University of Texas Medical Branch Department of Microbiology and Immunology (UTMB) for nearly a decade. Here, Dr. Mire took on several positions including Associate Professor and High-Containment Program Coordinator for Animal Research. As an Associate Professor, Dr. Mire developed research ideas in diagnostics, animal model development, vaccine, and therapeutic development in relation to emerging and zoonotic pathogens such as Ebola virus, Marburg virus, and Nipah virus. Dr. Mire received his Bachelor of Science in Biology from Rowan University, followed by receiving his Doctorate in Molecular Sciences with a focus on Virology from the University of Tennessee Health Science Center. In addition to his educational and employment history, Dr. Mire has been internationally recognized for performing leading research on emerging pathogens to develop preventative measures against emerging and zoonotic pathogens.
Dr. Lisa Hensley serves as the research leader for the Zoonotic and Emerging Disease Research Unit, or ZEDRU, located at the National Bio and Agro-Defense Facility (NBAF), which is operated by the U.S. Department of Agriculture (USDA). Dr. Hensley’s team at NBAF focus research efforts on zoonotic and emerging pathogens in large livestock and look for ways to interrupt or stop diseases, which is something USDA scientists cannot do anywhere else in the U.S. at the highest level of biocontainment or BSL-4.Before joining the USDA team at NBAF, Dr. Hensley served as the associate director for science at the National Institutes of Health’s Integrated Research Facility in Frederick, Maryland, where she was responsible for developing and managing a multidiscipline/multifaceted research portfolio supporting biodefense, potential pandemic pathogens, and emerging infectious disease research.Dr. Hensley also served as the director of regulatory science for the Medical Countermeasures Initiative in the Office of the Commissioner at the Food and Drug Administration and was the chief of Viral Therapeutics at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). She has an extensive background in public health, obtaining her doctorate at the University of North Carolina at Chapel Hill and a master’s degree in immunology and infectious disease from The Bloomberg School of Public Health, Johns Hopkins University. She spent the last 25 years developing and characterizing animal models for high-consequence and emerging pathogens, including Ebola and Marburg, SARs, MERs, Variola, mpox (formerly monkeypox) and other viruses. She used these models to develop, evaluate and help advance candidate countermeasures, including therapeutics, post-exposure prophylaxes, vaccines, and diagnostics to improve national and global health.Beyond the confines of the maximum containment laboratory, Dr. Hensley worked in remote locations such as West and Central Africa, where she established research laboratories to respond to outbreaks and conduct clinical trials in low-resource environments. She is considered one of the world’s leading subject matter experts on emerging diseases and high-consequence pathogens. She is one of few scientists with experience in the development of medical countermeasures from discovery topre-clinical evaluation and through clinical trials. Dr. Hensley has authored over 250 peer-reviewed scientific papers and book chapters and holds multiple patents.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 1:00 PM – 5:00 PM
20. No Resources? No Problem! A Dynamic Workshop for Improving Biosafety Program Visibility and Leadership Engagement
Building a holistic and comprehensive biorisk management program requires serious leadership commitment across your organization in order to drive successful mitigation strategies and compliance metrics. Biosafety Officers alone cannot develop, maintain, or continuously improve safety programs and require infrastructural support both within safety verticals as well as externally across divisions. It’s easy to lose sight of key objectives and results when faced with a mountain of operational issues, frustrated by a lack of resources, and feeling disconnected from leadership. Where do you begin when standing up a new biosafety program? What about implementing enterprise risk management solutions to mature an existing one? What are the pitfalls to avoid and how do you strategically engage leadership? This course will reinforce cornerstone pieces of biosafety program management with four highly interactive hands-on exercises to help drive solutions at your respective institutions. These exercises include leading indicator metrics, SOAR analysis, accountability and responsibility, and how to use appreciative inquiry as a tool for continuous improvement.
Objectives:
- Critique your respective biosafety program’s strengths and opportunities for improvement, both short and long term, and how to drive leadership engagement for support
- Establish a solutions-oriented approach that include leading indicator metrics based on SMART principles (specific, measurable, attainable, relevant, time-bound).
- Participate in hands-on exercises (4) and a discussion to foment tangible strategies to bring back to your institution, with a special emphasis on responsibility and accountability in safety program management
Suggested Background: None
Target Audience: All Safety Professionals, All Biosafety Professionals
Audience Level: Basic
COURSE FACULTY
AJ serves as the Global Director of Biosafety and Toxicology at FUJIFILM Diosynth Biotechnologies and is part of the global quality leadership team. In this critical role, he oversees safety operations for both patients and workers across 6 campuses spanning Europe and North America, assisting in and harmonizing hazard identification, risk assessment, risk mitigation, and risk monitoring strategies. AJ describes his role as a “safety diplomat” across the company’s operations landscape, with his core belief that a successful safety leadership position is predicated on collaborating with stakeholders across scientific, operational, quality and environmental health and safety (EHS) infrastructures, as well as both engaging and empowering leadership. Before joining FUJIFILM Diosynth Biotechnologies, AJ worked in various capacities as a biosafety and operations consultant in the Greater Boston, MA area and across the United States. He has audited, inspected, or provided gap analyses for laboratories at numerous multinational life science corporations, academic institutions, biotechnology start-ups, as well as various government agencies. He received his BS in Microbiology and Classics from the University of New Hampshire, a PhD in Biomedical Science with a concentration in Molecular Biology and Biophysics from the University of Connecticut Health Center and a MS in Clinical Toxicology through the University of Florida. AJ is a Registered Biosafety Professional with the American Biological Safety Association (ABSA International), and a member of ABSA’s Scientific Program Committee. A passionate safety advocate, AJ is active in both biosafety and toxicology professional organizations globally, and lives in the Boston, MA area.
As the Global Biosafety Officer for FUJIFILM Diosynth Biotechnologies, Colleen brings a wealth of experience and expertise in biorisk management, cell & viral gene therapy, and GMP operations. In this role, she serves as a centralized subject matter expert to assist in all aspects of contract development and manufacturing (CDMO) operations surrounding biologically derived therapeutics, specifically: new product introductions, risk assessments, training, and regulatory compliance. Colleen previously served as the Lead Biosafety Officer for Spark Therapeutics, overseeing capital investment projects like their new Gene Therapy Innovation Center, scaling their AAV commercial platform, and was a pivotal SME in the success of Luxturna®, the first ever FDA approved viral gene therapy for the treatment of inherited retinal dystrophy. Previous to this, she worked as the biosafety officer at the University of Pennsylvania where she partnered with Dr. Carl June on the first ever CAR-T Cell therapy, Kymriah®. Colleen has a B.S. in neuroscience from Penn State University, holds a Ph.D. in Neuroscience from the University of Pennsylvania, is a registered biosafety professional though the American Biological Safety Association (ABSA International), and is the chair of ABSA’s Scientific Program Committee. She currently lives in Philadelphia, PA with her husband and 7-year-old son, as well as their Boston Terrier puppy, Millie.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, November 3, 2024, 1:00 PM – 5:00 PM
21. Lessons Learned to Improve Biosafety
Preventing laboratory-acquired infections (LAIs) is a challenge for laboratory managers and biosafety professionals, especially when dealing with an emerging pathogen. It is extremely important to quickly determine if there has been an exposure, how many may have been exposed, what steps need to happen next, including any prophylaxis, root cause analysis, gaps in the biosafety plan, and additional mitigation measures that need to be implemented. This interactive course will examine published papers from the ABSA LAI Database on laboratory acquired infections and exposures to determine what we can learn to prevent future exposures. Attendees will thoroughly examine the literature on the history of lab-acquired infections, review specific published articles, utilize the Association of Public Health Laboratories (APHL) ‘Laboratory Exposure Assessment and Symptom Monitoring Guide’ (exposure assessment tool) to assess exposures, analyze data to identify root causes of exposures, discuss identified gaps, and establish additional steps required to mitigate risks. Afterwards, attendees will divide into groups and receive new scenarios from the database. Using the APHL exposure assessment tool, they will apply the process demonstrated earlier—from determining exposure to conducting root cause analysis, identifying gaps, and proposing mitigation steps to prevent recurrence. Attendees will then learn to utilize published data on lab-acquired infections and these tools to safely handle emerging pathogens.
Objectives:
- Describe how the ABSA LAI database can be used for biosafety training and determining how to safely work with emerging pathogens
- Utilize the APHL exposure assessment tool to assess real-life laboratory incidents for potential exposures and to help guide prophylaxis if indicated
- Analyze actual laboratory incidents to determine the root cause and what steps are necessary to mitigate future incidents
Suggested Background: Fundamentals of Biosafety, Risk Assessment
Target Audience: All Safety Professionals, Laboratory Workers
Audience Level: Intermediate
COURSE FACULTY
Dr. Pentella is a Clinical Professor at the University of Iowa, College of Public Health and Director of the Iowa State Hygienic Laboratory. His experience spans over forty years in clinical microbiology and public health laboratories. He is certified as an American Board of Medical Microbiology Diplomate, a specialist in microbiology through the American Society for Clinical Pathology and certified in infection control through the Association of Professionals in Infection Control. Dr. Pentella is a member of the APHL Biosafety and Biosecurity Committee, Antibiotic Resistance Lab Workgroup, the Infectious Disease Committee, and the Respiratory Viruses Subcommittee. He has made several contributions that have improved the practice of clinical microbiology and biosafety. He has written over 50 articles and twenty book chapters.
Erin Bowles is the Laboratory Network Coordinator for the Wisconsin State Laboratory of Hygiene’s Communicable Disease Division, where she provides outreach and education to more than 125 laboratories in Wisconsin in order to ensure a coordinated statewide response to any biological threats of public health importance. Her background in clinical microbiology and expertise in biosafety serve her well as a member of APHL’s Workforce Development Committee, the Sentinel Laboratory Outreach and Partnership Subcommittee, and the Sentinel Laboratory Training Special Interest Group. Some of the committee projects that she has contributed to are revisions to the ASM Sentinel Level Clinical Laboratory Guidelines and the development of risk assessment training and biosafety tools such as the “Clinical Laboratory Preparedness and Response Guide”.
Shoolah Escott is currently an independent, Biosafety, Biosecurity, and Bioterrorism Preparedness Trainer and a COVID-19 Contact Tracer with Partners In Health. She was the Biosafety Manager and ARO at the MA State Public Health Laboratory for over 2 years where she provided biosafety training and support to over 50 clinical laboratories and to internal public health laboratory staff. She worked for APHL/CDC National Laboratory Training Network, CDC Laboratory Training Branch for over 17 years developing, implementing, delivering, and presenting national training programs in biosafety, biosecurity and bioterrorism preparedness. She has a strong background in clinical microbiology and was the safety officer for the Memorial Hospital clinical laboratory. Currently, she serves on several ABSA and APHL committees. Here are a few key biosafety accomplishments: What Constitutes an Effective Biosafety Plan at the World Microbe Forum; Biosafety and Biosecurity: Minimizing the Risks in the Laboratory and Clinical Laboratory Biosafety Risk Assessment seminars presented nationally multiple times; and the lead on the initial development and revision of the Clinical Laboratory Preparedness and Response Guide.
Michael Perry, MS, MS Ed
Associate Director of the Biodefense Laboratory | Alternate Responsible Official
New York State Department of Health—Wadsworth Center
Albany, NY
Michael Perry is the associate director of the Biodefense Laboratory at the New York State Department of Health – Wadsworth Center. As the ARO, APHL Biosafety and Biosecurity committee member and a member of the Wadsworth Center institutional biosafety committee, Michael has extensive training and expertise in biosafety. As part of the Global Health Security Agenda, Michael was the lead trainer for APHL’s Global Health program, developing and providing trainings in the proper use, operation, and maintenance of biological safety cabinets and biorisk management for international public health laboratorians in Africa. Over the last 10 years, Michael has conducted numerous sentinel laboratory site visit which focused on the evaluation of both laboratory biosafety which a focus on assistance with risk assessments and risk mitigation strategies.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, November 3, 2024, 1:00 PM – 5:00 PM
22. Navigating Regulatory Audits in Biosafety: Strategies for Success
In biosafety, regulatory compliance is paramount to ensure the safe handling of biological materials and maintain the integrity of research and healthcare activities. This course is designed to equip biosafety professionals, laboratory managers, and clinical research personnel with the knowledge and strategies to prepare for and successfully navigate regulatory audits. The course, filled with practical and applicable content, will cover critical regulatory frameworks relevant to biosafety, including those outlined by the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Occupational Safety and Health Administration (OSHA). Attendees will gain insights into audit preparation techniques, documentation requirements, and best practices for ensuring compliance with regulatory standards. Through interactive discussions, case studies, and mock audit scenarios, attendees will learn how to identify potential audit pitfalls, address non-compliance issues, and implement corrective actions to strengthen their biosafety programs. Whether preparing for routine inspections or facing an unanticipated audit, this course will provide invaluable guidance and practical strategies to navigate regulatory audits confidently and successfully.
Objectives:
- Develop a comprehensive audit preparation plan incorporating documentation requirements outlined by regulatory agencies such as the CDC, NIH, and OSHA
- Demonstrate proficiency in identifying potential audit pitfalls and addressing non-compliance issues within a biosafety program
- Interpret audit findings and implement corrective actions to strengthen a biosafety program and improve regulatory compliance practices
Suggested Background: None
Target Audience: All Safety Professionals, New Biosafety Professionals, Laboratory Worker
Audience Level: Intermediate
COURSE FACULTY
Sarah Ziegler, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM)Sitero
Coral Gables, FL
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.